Cardiomyokines from the heart

Cardiomyokines from the heart The heart is regarded as an endocrine organ as well as a pump for circulation, since atrial natriuretic peptide (ANP) and brain natriuretic peptide (BNP) were discovered in cardiomyocytes to be secreted as hormones. Both ANP and BNP bind to their receptors expressed on remote organs, such as kidneys and blood vessels; therefore, the heart controls the circulation by pumping blood and by secreting endocrine peptides. Cardiomyocytes secrete other peptides besides natriuretic peptides. Although most of such cardiomyocyte-derived peptides act on the heart in autocrine/paracrine fashions, several peptides target remote organs. In this review, to overview current knowledge of endocrine properties of the heart, we focus on cardiomyocyte-derived peptides (cardiomyokines) that act on the remote organs as well as the heart. Cardiomyokines act on remote organs to regulate cardiovascular homeostasis, systemic metabolism, and inflammation. Therefore, through its endocrine function, the heart can maintain physiological conditions and prevent organ damage under pathological conditions. http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Cellular and Molecular Life Sciences Springer Journals

Cardiomyokines from the heart

14 pages
Read Article

Loading next page...
 
/lp/springer_journal/cardiomyokines-from-the-heart-Ay0If6U0ET
Publisher
Springer Journals
Copyright
Copyright © 2017 by Springer International Publishing AG, part of Springer Nature
Subject
Life Sciences; Cell Biology; Biomedicine, general; Life Sciences, general; Biochemistry, general
ISSN
1420-682X
eISSN
1420-9071
D.O.I.
10.1007/s00018-017-2723-6
Publisher site
See Article on Publisher Site

Abstract

The heart is regarded as an endocrine organ as well as a pump for circulation, since atrial natriuretic peptide (ANP) and brain natriuretic peptide (BNP) were discovered in cardiomyocytes to be secreted as hormones. Both ANP and BNP bind to their receptors expressed on remote organs, such as kidneys and blood vessels; therefore, the heart controls the circulation by pumping blood and by secreting endocrine peptides. Cardiomyocytes secrete other peptides besides natriuretic peptides. Although most of such cardiomyocyte-derived peptides act on the heart in autocrine/paracrine fashions, several peptides target remote organs. In this review, to overview current knowledge of endocrine properties of the heart, we focus on cardiomyocyte-derived peptides (cardiomyokines) that act on the remote organs as well as the heart. Cardiomyokines act on remote organs to regulate cardiovascular homeostasis, systemic metabolism, and inflammation. Therefore, through its endocrine function, the heart can maintain physiological conditions and prevent organ damage under pathological conditions.

Journal

Cellular and Molecular Life Sciences – Springer Journals

Published: Dec 13, 2017

References

  • The heart as an endocrine organ
    Ogawa, T; Bold, AJ
  • Atrial natriuretic factor: a hormone produced by the heart
    Bold, AJ
  • A rapid and potent natriuretic response to intravenous injection of atrial myocardial extract in rats
    Bold, AJ; Borenstein, HB; Veress, AT; Sonnenberg, H
  • Cardionatrin I—a novel heart peptide with potent diuretic and natriuretic properties
    Bold, AJ; Flynn, TG
  • The amino acid sequence of an atrial peptide with potent diuretic and natriuretic properties
    Flynn, TG; Bold, ML; Bold, AJ
  • Purification and complete amino acid sequence of alpha-human atrial natriuretic polypeptide (alpha-hANP)
    Kangawa, K; Matsuo, H
  • Isolation and nucleotide sequence of a cloned cardionatrin cDNA
    Kennedy, BP; Marsden, JJ; Flynn, TG; Bold, AJ; Davies, PL
  • A new natriuretic peptide in porcine brain
    Sudoh, T; Kangawa, K; Minamino, N; Matsuo, H
  • C-type natriuretic peptide (CNP): a new member of natriuretic peptide family identified in porcine brain
    Sudoh, T; Minamino, N; Kangawa, K; Matsuo, H
  • The cardiokine story unfolds: ischemic stress-induced protein secretion in the heart
    Doroudgar, S; Glembotski, CC
  • Cardiac extracellular vesicles in normal and infarcted heart
    Chistiakov, DA; Orekhov, AN; Bobryshev, YV
  • Cardiokines: recent progress in elucidating the cardiac secretome
    Shimano, M; Ouchi, N; Walsh, K
  • Functions for the cardiomyokine, MANF, in cardioprotection, hypertrophy and heart failure
    Glembotski, CC
  • Metabolic actions of natriuretic peptides and therapeutic potential in the metabolic syndrome
    Schlueter, N; Sterke, A; Willmes, DM; Spranger, J; Jordan, J; Birkenfeld, AL
  • Brain natriuretic peptide as a novel cardiac hormone in humans. Evidence for an exquisite dual natriuretic peptide system, atrial natriuretic peptide and brain natriuretic peptide
    Mukoyama, M; Nakao, K; Hosoda, K; Suga, S; Saito, Y; Ogawa, Y; Shirakami, G; Jougasaki, M; Obata, K; Yasue, H
  • Endothelial production of C-type natriuretic peptide and its marked augmentation by transforming growth factor-beta. Possible existence of “vascular natriuretic peptide system”
    Suga, S; Nakao, K; Itoh, H; Komatsu, Y; Ogawa, Y; Hama, N; Imura, H
  • C-type natriuretic peptide (CNP) in rats and humans
    Komatsu, Y; Nakao, K; Suga, S; Ogawa, Y; Mukoyama, M; Arai, H; Shirakami, G; Hosoda, K; Nakagawa, O; Hama, N
  • Organ-specific mRNA distribution of C-type natriuretic peptide in neonatal and adult mice
    Stepan, H; Leitner, E; Bader, M; Walther, T
  • Natriuretic peptide system: an overview of studies using genetically engineered animal models
    Kishimoto, I; Tokudome, T; Nakao, K; Kangawa, K
  • Differential activation by atrial and brain natriuretic peptides of two different receptor guanylate cyclases
    Chang, MS; Lowe, DG; Lewis, M; Hellmiss, R; Chen, E; Goeddel, DV
  • A membrane form of guanylate cyclase is an atrial natriuretic peptide receptor
    Chinkers, M; Garbers, DL; Chang, MS; Lowe, DG; Chin, HM; Goeddel, DV; Schulz, S
  • Atrial natriuretic peptide clearance receptor. Complete sequence and functional expression of cDNA clones
    Fuller, F; Porter, JG; Arfsten, AE; Miller, J; Schilling, JW; Scarborough, RM; Lewicki, JA; Schenk, DB
  • The primary structure of a plasma membrane guanylate cyclase demonstrates diversity within this new receptor family
    Schulz, S; Singh, S; Bellet, RA; Singh, G; Tubb, DJ; Chin, H; Garbers, DL
  • Cytoplasmic domain of natriuretic peptide receptor-C inhibits adenylyl cyclase. Involvement of a pertussis toxin-sensitive G protein
    Anand-Srivastava, MB; Sehl, PD; Lowe, DG
  • Selective activation of the B natriuretic peptide receptor by C-type natriuretic peptide (CNP)
    Koller, KJ; Lowe, DG; Bennett, GL; Minamino, N; Kangawa, K; Matsuo, H; Goeddel, DV
  • Receptor selectivity of natriuretic peptide family, atrial natriuretic peptide, brain natriuretic peptide, and C-type natriuretic peptide
    Suga, S; Nakao, K; Hosoda, K; Mukoyama, M; Ogawa, Y; Shirakami, G; Arai, H; Saito, Y; Kambayashi, Y; Inouye, K
  • Mechanisms of regulated unconventional protein secretion
    Nickel, W; Rabouille, C
  • Alpha 1-adrenergic stimulation of isolated rat atria results in discoordinate increases in natriuretic peptide secretion and gene expression and enhances Egr-1 and c-Myc expression
    Bruneau, BG; Piazza, LA; Bold, AJ
  • Endothelin is a potent secretagogue for atrial natriuretic peptide in cultured rat atrial myocytes
    Fukuda, Y; Hirata, Y; Yoshimi, H; Kojima, T; Kobayashi, Y; Yanagisawa, M; Masaki, T
  • Participation of G proteins in natriuretic peptide hormone secretion from heart atria
    Bensimon, M; Chang, AI; Bold, ML; Ponce, A; Carreras, D; Bold, AJ
  • BNP gene expression is specifically modulated by stretch and ET-1 in a new model of isolated rat atria
    Bruneau, BG; Piazza, LA; Bold, AJ
  • Regulation of stretch-activated ANP secretion by chloride channels
    Han, JH; Bai, GY; Park, JH; Yuan, K; Park, WH; Kim, SZ; Kim, SH
  • Block of stretch-activated atrial natriuretic peptide secretion by gadolinium in isolated rat atrium
    Laine, M; Arjamaa, O; Vuolteenaho, O; Ruskoaho, H; Weckstrom, M
  • Stretch-activated non-selective cation channel: a causal link between mechanical stretch and atrial natriuretic peptide secretion
    Zhang, YH; Youm, JB; Earm, YE
  • Thirty years of the heart as an endocrine organ: physiological role and clinical utility of cardiac natriuretic hormones
    Clerico, A; Giannoni, A; Vittorini, S; Passino, C
  • Atrial natriuretic peptide elevation in congestive heart failure in the human
    Burnett, JC; Kao, PC; Hu, DC; Heser, DW; Heublein, D; Granger, JP; Opgenorth, TJ; Reeder, GS
  • Plasma brain natriuretic peptide is a biochemical marker for the prediction of progressive ventricular remodeling after acute myocardial infarction
    Nagaya, N; Nishikimi, T; Goto, Y; Miyao, Y; Kobayashi, Y; Morii, I; Daikoku, S; Matsumoto, T; Miyazaki, S; Matsuoka, H; Takishita, S; Kangawa, K; Matsuo, H; Nonogi, H
  • Relationship between left ventricular geometry and natriuretic peptide levels in essential hypertension
    Nishikimi, T; Yoshihara, F; Morimoto, A; Ishikawa, K; Ishimitsu, T; Saito, Y; Kangawa, K; Matsuo, H; Omae, T; Matsuoka, H
  • Hypoxic activation of the atrial natriuretic peptide gene promoter through direct and indirect actions of hypoxia-inducible factor-1
    Chun, YS; Hyun, JY; Kwak, YG; Kim, IS; Kim, CH; Choi, E; Kim, MS; Park, JW
  • Cariporide (HOE642), a selective Na+–H+ exchange inhibitor, inhibits the mitochondrial death pathway
    Teshima, Y; Akao, M; Jones, SP; Marban, E
  • Atrial natriuretic peptide in hypoxia
    Chen, YF
  • Mechanism of hyperosmolality stimulation of ANP secretion: its dependency on calcium and sodium
    Schiebinger, RJ; Joseph, CM; Li, Y; Cragoe, EJ
  • Atrial natriuretic peptide and brain natriuretic peptide coexist in the secretory granules of human cardiac myocytes
    Nakamura, S; Naruse, M; Naruse, K; Kawana, M; Nishikawa, T; Hosoda, S; Tanaka, I; Yoshimi, T; Yoshihara, I; Inagami, T
  • Evaluation of atrial natriuretic peptide and brain natriuretic peptide in atrial granules of rats with experimental congestive heart failure
    Bialik, GM; Abassi, ZA; Hammel, I; Winaver, J; Lewinson, D
  • Increased human brain natriuretic peptide in congestive heart failure
    Mukoyama, M; Nakao, K; Saito, Y; Ogawa, Y; Hosoda, K; Suga, S; Shirakami, G; Jougasaki, M; Imura, H
  • Selective upregulation of cardiac brain natriuretic peptide at the transcriptional and translational levels by pro-inflammatory cytokines and by conditioned medium derived from mixed lymphocyte reactions via p38 MAP kinase
    Ma, KK; Ogawa, T; Bold, AJ
  • Coordination of growth and endoplasmic reticulum stress signaling by regulator of calcineurin 1 (RCAN1), a novel ATF6-inducible gene
    Belmont, PJ; Tadimalla, A; Chen, WJ; Martindale, JJ; Thuerauf, DJ; Marcinko, M; Gude, N; Sussman, MA; Glembotski, CC
  • Signal integration in the endoplasmic reticulum unfolded protein response
    Ron, D; Walter, P
  • Activation of the unfolded protein response in infarcted mouse heart and hypoxic cultured cardiac myocytes
    Thuerauf, DJ; Marcinko, M; Gude, N; Rubio, M; Sussman, MA; Glembotski, CC
  • X-box binding protein 1 regulates brain natriuretic peptide through a novel AP1/CRE-like element in cardiomyocytes
    Sawada, T; Minamino, T; Fu, HY; Asai, M; Okuda, K; Isomura, T; Yamazaki, S; Asano, Y; Okada, K; Tsukamoto, O; Sanada, S; Asanuma, H; Asakura, M; Takashima, S; Kitakaze, M; Komuro, I
  • Inhibitory regulation of hypertrophy by endogenous atrial natriuretic peptide in cultured cardiac myocytes
    Horio, T; Nishikimi, T; Yoshihara, F; Matsuo, H; Takishita, S; Kangawa, K
  • Hypertension, cardiac hypertrophy, and sudden death in mice lacking natriuretic peptide receptor A
    Oliver, PM; Fox, JE; Kim, R; Rockman, HA; Kim, HS; Reddick, RL; Pandey, KN; Milgram, SL; Smithies, O; Maeda, N
  • Pressure-independent cardiac hypertrophy in mice with cardiomyocyte-restricted inactivation of the atrial natriuretic peptide receptor guanylyl cyclase-A
    Holtwick, R; Eickels, M; Skryabin, BV; Baba, HA; Bubikat, A; Begrow, F; Schneider, MD; Garbers, DL; Kuhn, M
  • Genetically altered mutant mouse models of guanylyl cyclase/natriuretic peptide receptor-A exhibit the cardiac expression of proinflammatory mediators in a gene-dose-dependent manner
    Vellaichamy, E; Das, S; Subramanian, U; Maeda, N; Pandey, KN
  • Atrial natriuretic peptide inhibits angiotensin II-stimulated proliferation in fetal cardiomyocytes
    O’Tierney, PF; Chattergoon, NN; Louey, S; Giraud, GD; Thornburg, KL
  • Differential activation of natriuretic peptide receptors modulates cardiomyocyte proliferation during development
    Becker, JR; Chatterjee, S; Robinson, TY; Bennett, JS; Panakova, D; Galindo, CL; Zhong, L; Shin, JT; Coy, SM; Kelly, AE; Roden, DM; Lim, CC; MacRae, CA
  • B-type natriuretic peptide exerts broad functional opposition to transforming growth factor-beta in primary human cardiac fibroblasts: fibrosis, myofibroblast conversion, proliferation, and inflammation
    Kapoun, AM; Liang, F; O’Young, G; Damm, DL; Quon, D; White, RT; Munson, K; Lam, A; Schreiner, GF; Protter, AA
  • Effect of atrial natriuretic peptide and cyclic GMP phosphodiesterase inhibition on collagen synthesis by adult cardiac fibroblasts
    Redondo, J; Bishop, JE; Wilkins, MR
  • Effect of neutral endopeptidase inhibitor on endogenous atrial natriuretic peptide as a paracrine factor in cultured cardiac fibroblasts
    Maki, T; Horio, T; Yoshihara, F; Suga, S; Takeo, S; Matsuo, H; Kangawa, K
  • Cardiac fibrosis in mice lacking brain natriuretic peptide
    Tamura, N; Ogawa, Y; Chusho, H; Nakamura, K; Nakao, K; Suda, M; Kasahara, M; Hashimoto, R; Katsuura, G; Mukoyama, M; Itoh, H; Saito, Y; Tanaka, I; Otani, H; Katsuki, M
  • Involvement of the NF-kappa B/matrix metalloproteinase pathway in cardiac fibrosis of mice lacking guanylyl cyclase/natriuretic peptide receptor A
    Vellaichamy, E; Khurana, ML; Fink, J; Pandey, KN
  • Smooth muscle-selective deletion of guanylyl cyclase-A prevents the acute but not chronic effects of ANP on blood pressure
    Holtwick, R; Gotthardt, M; Skryabin, B; Steinmetz, M; Potthast, R; Zetsche, B; Hammer, RE; Herz, J; Kuhn, M
  • Vascular endothelium is critically involved in the hypotensive and hypovolemic actions of atrial natriuretic peptide
    Sabrane, K; Kruse, MN; Fabritz, L; Zetsche, B; Mitko, D; Skryabin, BV; Zwiener, M; Baba, HA; Yanagisawa, M; Kuhn, M
  • Effects of synthetic atrial natriuretic factor on renal function and renin release
    Burnett, JC; Granger, JP; Opgenorth, TJ
  • Atrial natriuretic peptide causes pre-glomerular vasodilatation and post-glomerular vasoconstriction in rat kidney
    Marin-Grez, M; Fleming, JT; Steinhausen, M
  • Atrial natriuretic factor inhibits sodium transport in medullary collecting duct
    Sonnenberg, H; Honrath, U; Chong, CK; Wilson, DR
  • Atrial natriuretic peptides inhibit conductive sodium uptake by rabbit inner medullary collecting duct cells
    Zeidel, ML; Kikeri, D; Silva, P; Burrowes, M; Brenner, BM
  • Angiotensin II stimulates and atrial natriuretic peptide inhibits human visceral adipocyte growth
    Sarzani, R; Marcucci, P; Salvi, F; Bordicchia, M; Espinosa, E; Mucci, L; Lorenzetti, B; Minardi, D; Muzzonigro, G; Dessi-Fulgheri, P; Rappelli, A
  • Natriuretic peptides: a new lipolytic pathway in human adipocytes
    Sengenes, C; Berlan, M; Glisezinski, I; Lafontan, M; Galitzky, J
  • Involvement of a cGMP-dependent pathway in the natriuretic peptide-mediated hormone-sensitive lipase phosphorylation in human adipocytes
    Sengenes, C; Bouloumie, A; Hauner, H; Berlan, M; Busse, R; Lafontan, M; Galitzky, J
  • Beta-adrenergic and atrial natriuretic peptide interactions on human cardiovascular and metabolic regulation
    Birkenfeld, AL; Boschmann, M; Moro, C; Adams, F; Heusser, K; Tank, J; Diedrich, A; Schroeder, C; Franke, G; Berlan, M; Luft, FC; Lafontan, M; Jordan, J
  • Aerobic exercise training improves atrial natriuretic peptide and catecholamine-mediated lipolysis in obese women with polycystic ovary syndrome
    Moro, C; Pasarica, M; Elkind-Hirsch, K; Redman, LM
  • Training enhances ANP lipid-mobilizing action in adipose tissue of overweight men
    Moro, C; Pillard, F; Glisezinski, I; Harant, I; Riviere, D; Stich, V; Lafontan, M; Crampes, F; Berlan, M
  • Cardiac natriuretic peptides act via p38 MAPK to induce the brown fat thermogenic program in mouse and human adipocytes
    Bordicchia, M; Liu, D; Amri, EZ; Ailhaud, G; Dessi-Fulgheri, P; Zhang, C; Takahashi, N; Sarzani, R; Collins, S
  • Modulating fatty acid oxidation in heart failure
    Lionetti, V; Stanley, WC; Recchia, FA
  • Renin–angiotensin system, natriuretic peptides, obesity, metabolic syndrome, and hypertension: an integrated view in humans
    Sarzani, R; Salvi, F; Dessi-Fulgheri, P; Rappelli, A
  • Natriuretic peptides/cGMP/cGMP-dependent protein kinase cascades promote muscle mitochondrial biogenesis and prevent obesity
    Miyashita, K; Itoh, H; Tsujimoto, H; Tamura, N; Fukunaga, Y; Sone, M; Yamahara, K; Taura, D; Inuzuka, M; Sonoyama, T; Nakao, K
  • Natriuretic peptides enhance the oxidative capacity of human skeletal muscle
    Engeli, S; Birkenfeld, AL; Badin, PM; Bourlier, V; Louche, K; Viguerie, N; Thalamas, C; Montastier, E; Larrouy, D; Harant, I; Glisezinski, I; Lieske, S; Reinke, J; Beckmann, B; Langin, D; Jordan, J; Moro, C
  • Ghrelin, a novel growth hormone-releasing acylated peptide, is synthesized in a distinct endocrine cell type in the gastrointestinal tracts of rats and humans
    Date, Y; Kojima, M; Hosoda, H; Sawaguchi, A; Mondal, MS; Suganuma, T; Matsukura, S; Kangawa, K; Nakazato, M
  • Ghrelin is a growth-hormone-releasing acylated peptide from stomach
    Kojima, M; Hosoda, H; Date, Y; Nakazato, M; Matsuo, H; Kangawa, K
  • Ghrelin induces adiposity in rodents
    Tschop, M; Smiley, DL; Heiman, ML
  • Somatostatin suppresses ghrelin secretion from the rat stomach
    Shimada, M; Date, Y; Mondal, MS; Toshinai, K; Shimbara, T; Fukunaga, K; Murakami, N; Miyazato, M; Kangawa, K; Yoshimatsu, H; Matsuo, H; Nakazato, M
  • Reciprocal paracrine pathways link atrial natriuretic peptide and somatostatin secretion in the antrum of the stomach
    Gower, WR; McCuen, RW; Arimura, A; Coy, DA; Dietz, JR; Landon, CS; Schubert, ML
  • B-type natriuretic peptide modulates ghrelin, hunger, and satiety in healthy men
    Vila, G; Grimm, G; Resl, M; Heinisch, B; Einwallner, E; Esterbauer, H; Dieplinger, B; Mueller, T; Luger, A; Clodi, M
  • Protective and pathogenic functions of macrophage subsets
    Murray, PJ; Wynn, TA
  • Autocrine regulation of inducible nitric-oxide synthase in macrophages by atrial natriuretic peptide
    Kiemer, AK; Vollmar, AM
  • Atrial natriuretic peptide inhibits the production of adipokines and cytokines linked to inflammation and insulin resistance in human subcutaneous adipose tissue
    Moro, C; Klimcakova, E; Lolmede, K; Berlan, M; Lafontan, M; Stich, V; Bouloumie, A; Galitzky, J; Arner, P; Langin, D
  • Protective effect of recombinant human brain natriuretic peptide on acute renal injury induced by endotoxin in canines
    Li, N; Jin, HX; Song, Z; Bai, CZ; Cui, Y; Gao, Y
  • Protective effects of recombinant human brain natriuretic peptide against LPS-induced acute lung injury in dogs
    Song, Z; Cui, Y; Ding, MZ; Jin, HX; Gao, Y
  • Recombinant human brain natriuretic peptide attenuates trauma-/haemorrhagic shock-induced acute lung injury through inhibiting oxidative stress and the NF-kappaB-dependent inflammatory/MMP-9 pathway
    Song, Z; Zhao, X; Liu, M; Jin, H; Wang, L; Hou, M; Gao, Y
  • Protective effect of rhBNP on intestinal injury in the canine models of sepsis
    Yang, H; Song, Z; Jin, H; Cui, Y; Hou, M; Gao, Y
  • Biochemistry and physiology of mammalian secreted phospholipases A2
    Lambeau, G; Gelb, MH
  • Secreted phospholipase A2 and mast cells
    Murakami, M; Taketomi, Y
  • Distinct arachidonate-releasing functions of mammalian secreted phospholipase A2 s in human embryonic kidney 293 and rat mastocytoma RBL-2H3 cells through heparan sulfate shuttling and external plasma membrane mechanisms
    Murakami, M; Koduri, RS; Enomoto, A; Shimbara, S; Seki, M; Yoshihara, K; Singer, A; Valentin, E; Ghomashchi, F; Lambeau, G; Gelb, MH; Kudo, I
  • Matrix metalloproteinase-2 negatively regulates cardiac secreted phospholipase A2 to modulate inflammation and fever
    Berry, E; Hernandez-Anzaldo, S; Ghomashchi, F; Lehner, R; Murakami, M; Gelb, MH; Kassiri, Z; Wang, X; Fernandez-Patron, C
  • Identification of a novel heart-liver axis: matrix metalloproteinase-2 negatively regulates cardiac secreted phospholipase A2 to modulate lipid metabolism and inflammation in the liver
    Hernandez-Anzaldo, S; Berry, E; Brglez, V; Leung, D; Yun, TJ; Lee, JS; Filep, JG; Kassiri, Z; Cheong, C; Lambeau, G; Lehner, R; Fernandez-Patron, C
  • Cloning from a mouse osteoblastic cell line of a set of transforming-growth-factor-beta 1-regulated genes, one of which seems to encode a follistatin-related polypeptide
    Shibanuma, M; Mashimo, J; Mita, A; Kuroki, T; Nose, K
  • DIP2 disco-interacting protein 2 homolog A (Drosophila) is a candidate receptor for follistatin-related protein/follistatin-like 1—analysis of their binding with TGF-beta superfamily proteins
    Tanaka, M; Murakami, K; Ozaki, S; Imura, Y; Tong, XP; Watanabe, T; Sawaki, T; Kawanami, T; Kawabata, D; Fujii, T; Usui, T; Masaki, Y; Fukushima, T; Jin, ZX; Umehara, H; Mimori, T
  • DIP2A functions as a FSTL1 receptor
    Ouchi, N; Asaumi, Y; Ohashi, K; Higuchi, A; Sono-Romanelli, S; Oshima, Y; Walsh, K
  • Therapeutic impact of follistatin-like 1 on myocardial ischemic injury in preclinical models
    Ogura, Y; Ouchi, N; Ohashi, K; Shibata, R; Kataoka, Y; Kambara, T; Kito, T; Maruyama, S; Yuasa, D; Matsuo, K; Enomoto, T; Uemura, Y; Miyabe, M; Ishii, M; Yamamoto, T; Shimizu, Y; Walsh, K; Murohara, T
  • Follistatin-like 1 is an Akt-regulated cardioprotective factor that is secreted by the heart
    Oshima, Y; Ouchi, N; Sato, K; Izumiya, Y; Pimentel, DR; Walsh, K
  • Developmental expression of mouse Follistatin-like 1 (Fstl1): dynamic regulation during organogenesis of the kidney and lung
    Adams, D; Larman, B; Oxburgh, L
  • Epicardial FSTL1 reconstitution regenerates the adult mammalian heart
    Wei, K; Serpooshan, V; Hurtado, C; Diez-Cunado, M; Zhao, M; Maruyama, S; Zhu, W; Fajardo, G; Noseda, M; Nakamura, K; Tian, X; Liu, Q; Wang, A; Matsuura, Y; Bushway, P; Cai, W; Savchenko, A; Mahmoudi, M; Schneider, MD; Hoff, MJ; Butte, MJ; Yang, PC; Walsh, K; Zhou, B; Bernstein, D; Mercola, M; Ruiz-Lozano, P
  • Cardiac myocyte follistatin-like 1 functions to attenuate hypertrophy following pressure overload
    Shimano, M; Ouchi, N; Nakamura, K; Wijk, B; Ohashi, K; Asaumi, Y; Higuchi, A; Pimentel, DR; Sam, F; Murohara, T; Hoff, MJ; Walsh, K
  • Follistatin-like 1 in chronic systolic heart failure: a marker of left ventricular remodeling
    El-Armouche, A; Ouchi, N; Tanaka, K; Doros, G; Wittkopper, K; Schulze, T; Eschenhagen, T; Walsh, K; Sam, F
  • Cardiac myocyte-derived follistatin-like 1 prevents renal injury in a subtotal nephrectomy model
    Hayakawa, S; Ohashi, K; Shibata, R; Kataoka, Y; Miyabe, M; Enomoto, T; Joki, Y; Shimizu, Y; Kambara, T; Uemura, Y; Yuasa, D; Ogawa, H; Matsuo, K; Hiramatsu-Ito, M; Hoff, MJ; Walsh, K; Murohara, T; Ouchi, N
  • Endothelin: 20 years from discovery to therapy
    Barton, M; Yanagisawa, M
  • A novel peptide vasoconstrictor, endothelin, is produced by vascular endothelium and modulates smooth muscle Ca2+ channels
    Yanagisawa, M; Kurihara, H; Kimura, S; Goto, K; Masaki, T
  • The human endothelin family: three structurally and pharmacologically distinct isopeptides predicted by three separate genes
    Inoue, A; Yanagisawa, M; Kimura, S; Kasuya, Y; Miyauchi, T; Goto, K; Masaki, T
  • Cloning and expression of a cDNA encoding an endothelin receptor
    Arai, H; Hori, S; Aramori, I; Ohkubo, H; Nakanishi, S
  • Cloning of a cDNA encoding a non-isopeptide-selective subtype of the endothelin receptor
    Sakurai, T; Yanagisawa, M; Takuwa, Y; Miyazaki, H; Kimura, S; Goto, K; Masaki, T
  • A review of pulmonary arterial hypertension: role of ambrisentan
    Barst, RJ
  • The discovery of endothelins
    Masaki, T
  • Evidence using immunoelectron microscopy for regulated and constitutive pathways in the transport and release of endothelin
    Russell, FD; Skepper, JN; Davenport, AP
  • Endothelin
    Davenport, AP; Hyndman, KA; Dhaun, N; Southan, C; Kohan, DE; Pollock, JS; Pollock, DM; Webb, DJ; Maguire, JJ
  • Endothelin-1 is produced and secreted by neonatal rat cardiac myocytes in vitro
    Suzuki, T; Kumazaki, T; Mitsui, Y
  • Low oxygen enhances endothelin-1 (ET-1) production and responsiveness to ET-1 in cultured cardiac myocytes
    Kagamu, H; Suzuki, T; Arakawa, M; Mitsui, Y
  • Endothelin-1 is involved in mechanical stress-induced cardiomyocyte hypertrophy
    Yamazaki, T; Komuro, I; Kudoh, S; Zou, Y; Shiojima, I; Hiroi, Y; Mizuno, T; Maemura, K; Kurihara, H; Aikawa, R; Takano, H; Yazaki, Y
  • Selective upregulation of cardiac endothelin system in patients with ischemic but not idiopathic dilated cardiomyopathy: endothelin-1 system in the human failing heart
    Serneri, GG; Cecioni, I; Vanni, S; Paniccia, R; Bandinelli, B; Vetere, A; Janming, X; Bertolozzi, I; Boddi, M; Lisi, GF; Sani, G; Modesti, PA
  • Mice with cardiomyocyte-specific disruption of the endothelin-1 gene are resistant to hyperthyroid cardiac hypertrophy
    Shohet, RV; Kisanuki, YY; Zhao, XS; Siddiquee, Z; Franco, F; Yanagisawa, M
  • Endogenous endothelin-1 is required for cardiomyocyte survival in vivo
    Zhao, XS; Pan, W; Bekeredjian, R; Shohet, RV
  • Role of endothelin in uteroplacental circulation and fetal vascular function
    Paradis, A; Zhang, L
  • The endocrine role for chromogranin A: a prohormone for peptides with regulatory properties
    Helle, KB; Corti, A; Metz-Boutigue, MH; Tota, B
  • The release of protein from the stimulated adrenal medulla
    Banks, P; Helle, K
  • Secretion of a chromaffin granule protein, chromogranin, from the adrenal gland after splanchnic stimulation
    Blaschko, H; Comline, RS; Schneider, FH; Silver, M; Smith, AD
  • Myocardial production of chromogranin A in human heart: a new regulatory peptide of cardiac function
    Pieroni, M; Corti, A; Tota, B; Curnis, F; Angelone, T; Colombo, B; Cerra, MC; Bellocci, F; Crea, F; Maseri, A
  • Catecholamines, cardiac natriuretic peptides and chromogranin A: evolution and physiopathology of a ‘whip-brake’ system of the endocrine heart
    Tota, B; Cerra, MC; Gattuso, A
  • Chromogranin A in heart failure; a novel neurohumoral factor and a predictor for mortality
    Ceconi, C; Ferrari, R; Bachetti, T; Opasich, C; Volterrani, M; Colombo, B; Parrinello, G; Corti, A
  • Chromogranin A. Storage and release in hypertension
    Takiyyuddin, MA; Cervenka, JH; Hsiao, RJ; Barbosa, JA; Parmer, RJ; O’Connor, DT
  • Characterization of natural vasostatin-containing peptides in rat heart
    Glattard, E; Angelone, T; Strub, JM; Corti, A; Aunis, D; Tota, B; Metz-Boutigue, MH; Goumon, Y
  • Vasostatin 1 activates eNOS in endothelial cells through a proteoglycan-dependent mechanism
    Ramella, R; Boero, O; Alloatti, G; Angelone, T; Levi, R; Gallo, MP
  • Recombinant N-terminal fragments of chromogranin-A modulate cardiac function of the Langendorff-perfused rat heart
    Cerra, MC; De, IL; Angelone, T; Corti, A; Tota, B
  • Vasostatin-1 stops structural remodeling and improves calcium handling via the eNOS-NO-PKG pathway in rat hearts subjected to chronic beta-adrenergic receptor activation
    Wang, D; Shan, Y; Huang, Y; Tang, Y; Chen, Y; Li, R; Yang, J; Huang, C
  • Endothelium-derived nitric oxide mediates the antiadrenergic effect of human vasostatin-1 in rat ventricular myocardium
    Gallo, MP; Levi, R; Ramella, R; Brero, A; Boero, O; Tota, B; Alloatti, G
  • The vasoinhibitory activity of bovine chromogranin A fragment (vasostatin) and its independence of extracellular calcium in isolated segments of human blood vessels
    Aardal, S; Helle, KB
  • Vasostatin, a calreticulin fragment, inhibits angiogenesis and suppresses tumor growth
    Pike, SE; Yao, L; Jones, KD; Cherney, B; Appella, E; Sakaguchi, K; Nakhasi, H; Teruya-Feldstein, J; Wirth, P; Gupta, G; Tosato, G
  • Chromogranin/secretogranin proteins in murine heart: myocardial production of chromogranin A fragment catestatin (Chga(364–384))
    Biswas, N; Curello, E; O’Connor, DT; Mahata, SK
  • Novel autocrine feedback control of catecholamine release. A discrete chromogranin a fragment is a noncompetitive nicotinic cholinergic antagonist
    Mahata, SK; O’Connor, DT; Mahata, M; Yoo, SH; Taupenot, L; Wu, H; Gill, BM; Parmer, RJ
  • Early decline in the catecholamine release-inhibitory peptide catestatin in humans at genetic risk of hypertension
    O’Connor, DT; Kailasam, MT; Kennedy, BP; Ziegler, MG; Yanaihara, N; Parmer, RJ
  • Glycosylated chromogranin A in heart failure: implications for processing and cardiomyocyte calcium homeostasis
    Ottesen, AH; Carlson, CR; Louch, WE; Dahl, MB; Sandbu, RA; Johansen, RF; Jarstadmarken, H; Bjoras, M; Hoiseth, AD; Brynildsen, J; Sjaastad, I; Stridsberg, M; Omland, T; Christensen, G; Rosjo, H
  • The antihypertensive chromogranin a peptide catestatin acts as a novel endocrine/paracrine modulator of cardiac inotropism and lusitropism
    Angelone, T; Quintieri, AM; Brar, BK; Limchaiyawat, PT; Tota, B; Mahata, SK; Cerra, MC
  • Mechanism of cardiovascular actions of the chromogranin A fragment catestatin in vivo
    Kennedy, BP; Mahata, SK; O’Connor, DT; Ziegler, MG
  • Hypertension from targeted ablation of chromogranin A can be rescued by the human ortholog
    Mahapatra, NR; O’Connor, DT; Vaingankar, SM; Hikim, AP; Mahata, M; Ray, S; Staite, E; Wu, H; Gu, Y; Dalton, N; Kennedy, BP; Ziegler, MG; Ross, J; Mahata, SK
  • Global disturbances in autonomic function yield cardiovascular instability and hypertension in the chromogranin a null mouse
    Gayen, JR; Gu, Y; O’Connor, DT; Mahata, SK
  • Pathophysiological roles of FGF signaling in the heart
    Itoh, N; Ohta, H
  • Receptor specificity of the fibroblast growth factor family. The complete mammalian FGF family
    Zhang, X; Ibrahimi, OA; Olsen, SK; Umemori, H; Mohammadi, M; Ornitz, DM
  • Molecular insights into the klotho-dependent, endocrine mode of action of fibroblast growth factor 19 subfamily members
    Goetz, R; Beenken, A; Ibrahimi, OA; Kalinina, J; Olsen, SK; Eliseenkova, AV; Xu, C; Neubert, TA; Zhang, F; Linhardt, RJ; Yu, X; White, KE; Inagaki, T; Kliewer, SA; Yamamoto, M; Kurosu, H; Ogawa, Y; Kuro-o, M; Lanske, B; Razzaque, MS; Mohammadi, M
  • Roles of FGF signals in heart development, health, and disease
    Itoh, N; Ohta, H; Nakayama, Y; Konishi, M
  • Novel insights into the cardio-protective effects of FGF21 in lean and obese rat hearts
    Patel, V; Adya, R; Chen, J; Ramanjaneya, M; Bari, MF; Bhudia, SK; Hillhouse, EW; Tan, BK; Randeva, HS
  • Fibroblast growth factor 21 protects the heart from apoptosis in a diabetic mouse model via extracellular signal-regulated kinase 1/2-dependent signalling pathway
    Zhang, C; Huang, Z; Gu, J; Yan, X; Lu, X; Zhou, S; Wang, S; Shao, M; Zhang, F; Cheng, P; Feng, W; Tan, Y; Li, X
  • Hepatic fibroblast growth factor 21 is regulated by PPARalpha and is a key mediator of hepatic lipid metabolism in ketotic states
    Badman, MK; Pissios, P; Kennedy, AR; Koukos, G; Flier, JS; Maratos-Flier, E
  • Endocrine regulation of the fasting response by PPARalpha-mediated induction of fibroblast growth factor 21
    Inagaki, T; Dutchak, P; Zhao, G; Ding, X; Gautron, L; Parameswara, V; Li, Y; Goetz, R; Mohammadi, M; Esser, V; Elmquist, JK; Gerard, RD; Burgess, SC; Hammer, RE; Mangelsdorf, DJ; Kliewer, SA
  • Fibroblast growth factor 21 induces glucose transporter-1 expression through activation of the serum response factor/Ets-like protein-1 in adipocytes
    Ge, X; Chen, C; Hui, X; Wang, Y; Lam, KS; Xu, A
  • FGF21 regulates PGC-1alpha and browning of white adipose tissues in adaptive thermogenesis
    Fisher, FM; Kleiner, S; Douris, N; Fox, EC; Mepani, RJ; Verdeguer, F; Wu, J; Kharitonenkov, A; Flier, JS; Maratos-Flier, E; Spiegelman, BM
  • FGF21 induces PGC-1alpha and regulates carbohydrate and fatty acid metabolism during the adaptive starvation response
    Potthoff, MJ; Inagaki, T; Satapati, S; Ding, X; He, T; Goetz, R; Mohammadi, M; Finck, BN; Mangelsdorf, DJ; Kliewer, SA; Burgess, SC
  • Fibroblast growth factor 21 corrects obesity in mice
    Coskun, T; Bina, HA; Schneider, MA; Dunbar, JD; Hu, CC; Chen, Y; Moller, DE; Kharitonenkov, A
  • FGF21 and cardiac physiopathology
    Planavila, A; Redondo-Angulo, I; Villarroya, F
  • Fibroblast growth factor 21 is induced upon cardiac stress and alters cardiac lipid homeostasis
    Brahma, MK; Adam, RC; Pollak, NM; Jaeger, D; Zierler, KA; Pocher, N; Schreiber, R; Romauch, M; Moustafa, T; Eder, S; Ruelicke, T; Preiss-Landl, K; Lass, A; Zechner, R; Haemmerle, G
  • Tissue-specific loss of DARS2 activates stress responses independently of respiratory chain deficiency in the heart
    Dogan, SA; Pujol, C; Maiti, P; Kukat, A; Wang, S; Hermans, S; Senft, K; Wibom, R; Rugarli, EI; Trifunovic, A
  • Fibroblast growth factor 21 protects against cardiac hypertrophy in mice
    Planavila, A; Redondo, I; Hondares, E; Vinciguerra, M; Munts, C; Iglesias, R; Gabrielli, LA; Sitges, M; Giralt, M; Bilsen, M; Villarroya, F
  • Fibroblast growth factor 21 protects the heart from oxidative stress
    Planavila, A; Redondo-Angulo, I; Ribas, F; Garrabou, G; Casademont, J; Giralt, M; Villarroya, F
  • Musclin, a novel skeletal muscle-derived secretory factor
    Nishizawa, H; Matsuda, M; Yamada, Y; Kawai, K; Suzuki, E; Makishima, M; Kitamura, T; Shimomura, I
  • Osteocrin, a novel bone-specific secreted protein that modulates the osteoblast phenotype
    Thomas, G; Moffatt, P; Salois, P; Gaumond, MH; Gingras, R; Godin, E; Miao, D; Goltzman, D; Lanctot, C
  • Osteocrin is a specific ligand of the natriuretic peptide clearance receptor that modulates bone growth
    Moffatt, P; Thomas, G; Sellin, K; Bessette, MC; Lafreniere, F; Akhouayri, O; St-Arnaud, R; Lanctot, C
  • Natriuretic peptides, their receptors, and cyclic guanosine monophosphate-dependent signaling functions
    Potter, LR; Abbey-Hosch, S; Dickey, DM
  • Osteocrin, a peptide secreted from the heart and other tissues, contributes to cranial osteogenesis and chondrogenesis in zebrafish
    Chiba, A; Watanabe-Takano, H; Terai, K; Fukui, H; Miyazaki, T; Uemura, M; Hashimoto, H; Hibi, M; Fukuhara, S; Mochizuki, N
  • The transforming growth factor-beta superfamily member growth-differentiation factor-15 protects the heart from ischemia/reperfusion injury
    Kempf, T; Eden, M; Strelau, J; Naguib, M; Willenbockel, C; Tongers, J; Heineke, J; Kotlarz, D; Xu, J; Molkentin, JD; Niessen, HW; Drexler, H; Wollert, KC
  • Activin A and follistatin-like 3 determine the susceptibility of heart to ischemic injury
    Oshima, Y; Ouchi, N; Shimano, M; Pimentel, DR; Papanicolaou, KN; Panse, KD; Tsuchida, K; Lara-Pezzi, E; Lee, SJ; Walsh, K
  • Bone morphogenetic protein-2—a potential autocrine/paracrine factor in mediating the stretch activated B-type and atrial natriuretic peptide expression in cardiac myocytes
    Tokola, H; Rysa, J; Pikkarainen, S; Hautala, N; Leskinen, H; Kerkela, R; Ilves, M; Aro, J; Vuolteenaho, O; Ritvos, O; Ruskoaho, H
  • Induction of cachexia in mice by systemically administered myostatin
    Zimmers, TA; Davies, MV; Koniaris, LG; Haynes, P; Esquela, AF; Tomkinson, KN; McPherron, AC; Wolfman, NM; Lee, SJ
  • Genetic deletion of myostatin from the heart prevents skeletal muscle atrophy in heart failure
    Heineke, J; Auger-Messier, M; Xu, J; Sargent, M; York, A; Welle, S; Molkentin, JD
  • GDF15 is a heart-derived hormone that regulates body growth
    Wang, T; Liu, J; McDonald, C; Lupino, K; Zhai, X; Wilkins, BJ; Hakonarson, H; Pei, L
  • Interactions between FGF21 and BMP-2 in osteogenesis
    Ishida, K; Haudenschild, DR
  • Parathyroid hormone-like protein is a secretory product of atrial myocytes
    Deftos, LJ; Burton, DW; Brandt, DW
  • Hsp20 functions as a novel cardiokine in promoting angiogenesis via activation of VEGFR2
    Zhang, X; Wang, X; Zhu, H; Kranias, EG; Tang, Y; Peng, T; Chang, J; Fan, GC
  • Cardiomyocytes mediate anti-angiogenesis in type 2 diabetic rats through the exosomal transfer of miR-320 into endothelial cells
    Wang, X; Huang, W; Liu, G; Cai, W; Millard, RW; Wang, Y; Chang, J; Peng, T; Fan, GC
  • MicroRNAs in heart failure: from biomarker to target for therapy
    Vegter, EL; Meer, P; Windt, LJ; Pinto, YM; Voors, AA
  • MicroRNAs: new players in heart failure
    Oliveira-Carvalho, V; Silva, MM; Guimaraes, GV; Bacal, F; Bocchi, EA
  • MicroRNA-133 controls cardiac hypertrophy
    Care, A; Catalucci, D; Felicetti, F; Bonci, D; Addario, A; Gallo, P; Bang, ML; Segnalini, P; Gu, Y; Dalton, ND; Elia, L; Latronico, MV; Hoydal, M; Autore, C; Russo, MA; Dorn, GW; Ellingsen, O; Ruiz-Lozano, P; Peterson, KL; Croce, CM; Peschle, C; Condorelli, G
  • Therapeutic inhibition of miR-208a improves cardiac function and survival during heart failure
    Montgomery, RL; Hullinger, TG; Semus, HM; Dickinson, BA; Seto, AG; Lynch, JM; Stack, C; Latimer, PA; Olson, EN; Rooij, E

You’re reading a free preview. Subscribe to read the entire article.

Try 2 weeks free now

DeepDyve is your
personal research library

It’s your single place to instantly
discover and read the research
that matters to you.

Enjoy affordable access to
over 18 million articles from more than
15,000 peer-reviewed journals.

All for just $49/month

Explore the DeepDyve Library

or browse the journals available

Search

Query the DeepDyve database, plus search all of PubMed and Google Scholar seamlessly

Organize

Save any article or search result from DeepDyve, PubMed, and Google Scholar... all in one place.

Access

Get unlimited, online access to over 18 million full-text articles from more than 15,000 scientific journals.

Your journals are on DeepDyve

Read from thousands of the leading scholarly journals from SpringerNature, Elsevier, Wiley-Blackwell, Oxford University Press and more.

All the latest content is available, no embargo periods.

See the journals in your area

DeepDyve

Freelancer

DeepDyve

Pro

Price

FREE

$49/month
$360/year

Save searches from
Google Scholar,
PubMed

Create lists to
organize your research

Export lists, citations

Read DeepDyve articles

Abstract access only

Unlimited access to over
18 million full-text articles

Print

20 pages / month

PDF Discount

20% off

Sign up
for free
Start 14 day
Free Trial